Current evidence supports the significant role of PDL1 in carcinogenesis, particularly in hepatocellular carcinoma (HCC), where the bidirectional regulation of PDL1 mediated by TP53/mechanistic Target of Rapamycin Complex 1 (mTORC1) has been elucidated. Here, TP53 is linked to hepatocellular carcinoma.